Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hanauer

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 3, 2020
In Vivo Generation of CAR T Cells Selectively in Human CD4<sup>+</sup> LymphocytesShiwani Agarwal, Julia D S Hanauer, Annika M Frank, et al.
The New England Journal of Medicine|June 30, 1994
Cyclosporine in severe ulcerative colitis refractory to steroid therapyS Lichtiger, D H Present, A Kornbluth, et al.
Bone Marrow Transplantation|February 1, 1996
Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancerJ D Bitran, B Samuels, L Klein, et al.
Gut|September 1, 1991
Double blind, placebo controlled trial of metronidazole in Crohn's diseaseL Sutherland, J Singleton, J Sessions, et al.
Experimental Hematology|June 1, 1996
A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cellsS Roman-Unfer, J D Bitran, L Garrison, et al.
The American Journal of Gastroenterology|August 5, 2000
Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitisS Hanauer, L I Good, M W Goodman, et al.
Oncotarget|March 22, 2018
CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphomaJulia D S Hanauer, Benjamin Rengstl, Dina Kleinlützum, et al.
The Pharmacogenomics Journal|October 1, 2008
Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African AmericansM A Perera, R K Thirumaran, N J Cox, et al.
Frontiers in Oncology|July 12, 2017
Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most EffectiveDina Kleinlützum, Julia D S Hanauer, Alexander Muik, et al.
The American Journal of Gastroenterology|August 26, 2015
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-TargetL Peyrin-Biroulet, W Sandborn, B E Sands, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 3, 2020
In Vivo Generation of CAR T Cells Selectively in Human CD4<sup>+</sup> LymphocytesShiwani Agarwal, Julia D S Hanauer, Annika M Frank, et al.
The New England Journal of Medicine|June 30, 1994
Cyclosporine in severe ulcerative colitis refractory to steroid therapyS Lichtiger, D H Present, A Kornbluth, et al.
Bone Marrow Transplantation|February 1, 1996
Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancerJ D Bitran, B Samuels, L Klein, et al.
Gut|September 1, 1991
Double blind, placebo controlled trial of metronidazole in Crohn's diseaseL Sutherland, J Singleton, J Sessions, et al.
Experimental Hematology|June 1, 1996
A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cellsS Roman-Unfer, J D Bitran, L Garrison, et al.
The American Journal of Gastroenterology|August 5, 2000
Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitisS Hanauer, L I Good, M W Goodman, et al.
Oncotarget|March 22, 2018
CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphomaJulia D S Hanauer, Benjamin Rengstl, Dina Kleinlützum, et al.
The Pharmacogenomics Journal|October 1, 2008
Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African AmericansM A Perera, R K Thirumaran, N J Cox, et al.
Frontiers in Oncology|July 12, 2017
Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most EffectiveDina Kleinlützum, Julia D S Hanauer, Alexander Muik, et al.
The American Journal of Gastroenterology|August 26, 2015
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-TargetL Peyrin-Biroulet, W Sandborn, B E Sands, et al.
Pageof 2